Fremanezumab
Fremanezumab is a pharmaceutical drug with 24 clinical trials. Currently 4 active trials ongoing. Historical success rate of 66.7%.
Success Metrics
Based on 10 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
58.8%
10 of 17 finished
41.2%
7 ended early
4
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fremanezumab Managed Access Program for Pediatric Patients
A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
Clinical Trials (24)
Fremanezumab Managed Access Program for Pediatric Patients
A Trial to Test if Fremanezumab is Effective in Preventing Migraine in Children and Adolescents
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Fremanezumab Treatment of Migraine in Women With Menstrual Migraine Ages 18-45
A Study to Test if Fremanezumab is Effective in Preventing Chronic Migraine in Participants 6 to 17 Years of Age
A Randomized, Double-Blind, Placebo-Controlled Study With an Open-Label Period on Efficacy and Safety of Fremanezumab in Chinese Adults With Migraine
Migraine Medication Effects on Urinary Symptoms
Improving the Perception of Stress and Mutuality in Caregivers (MI-DEAR Study) of Migraine Patients With Depressive Symptoms Treated With Fremanezumab: A Study to Evaluate Whether Fremanezumab Reduces the Impact on Caregivers and Increases Couple Reciprocity
CGRP Inhibition, Autonomic Function, and Migraine
Fremanezumab for the Prevention of Menstrually-related Migraine Attacks
Real World Effectiveness of Eptinezumab in Participants With Migraine
A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia
A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH)
Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study
Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain Syndrome
Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 24